A newly proposed framework expands acute traumatic brain injury (TBI) assessment beyond the Glasgow Coma Scale (GCS).

Although the 400-person study was too small to really compare clinical outcomes, Tanigaki said a count of major adverse ...

Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

And Arcutis Biotherapeutics announced approval of roflumilast (Zoryve) topical foam 0.3% for plaque psoriasis of the scalp ...

While rates of bile duct injury were similar with robotic-assisted cholecystectomy and laparoscopic cholecystectomy among ...

With all of the healthcare funding cuts currently going on in Washington, there is one health service that has survived ...

The outrage over prescription drug pricing in the U.S. is justified. Americans routinely pay two to three times more for ...

At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage repair (DDR)-deficient localized prostate cancer offered new insights -- but ...

A new FDA policy will make COVID boosters available for high-risk groups, but harder to get for many Americans.